Winnie Byanyima, head of UNAIDS, criticized the impact of reduced U.S. funding in combatting HIV. She proposed a deal to U.S.

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

The location is the company's headquarters for ... let go of an undisclosed number of employees tied to a project with Gilead Sciences’ Kite Pharma. Story Jan. 9 - IGM Biosciences: After ...

Gilead CEO Daniel O’Day saw another rise in his pay in 2024, reflecting the steadily upward trajectory of the company since he took the reins in 2019. O’Day received a compensation package of ...

News of potential federal budget cuts impacting HIV drugs in the U.S. was quickly reflected in a dip in share prices for top HIV drug maker Gilead Sciences last week. But, according to analysts at ...

"Stigma isn't just a social issue; it's a public health crisis." says Marcus Wilson, Gilead Senior Director, U.S. Public Affairs, HIV Advocacy. "It determines the quality of care that people ...

At a news briefing in Geneva, UNAIDS Executive Director Winnie Byanyima said that the deal would involve Trump enabling the U.S. company Gilead to produce and license its “magical” prevention ...

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

The Handmaid's Tale star Samira Wiley is opening up about her character returning to where it all began for the final season: Gilead. "I hadn't worn that dress since Season 1, since, like ...

“We love it,” said Allen. “It’s a filmmaking town. The crews are amazing. Everyone knows what they’re doing. Everyone cares about their job. It’s been really great.” Other Branch Out Films producers ...

Gilead Sciences' TROP2-directed drug Trodelvy has missed the target in another clinical trial, this time in urothelial carcinoma, the most common form of bladder cancer. The results of the TROPiCS ...